LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.06 | 27.76 | 754 | 360 | 2.0944 | 1.4427 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.76 | 27.76 | 13 | 401 | 0.0324 | -0.1787 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.76 | 27.76 | 738 | 401 | 1.8397 | 1.3428 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 8.76 | 27.76 | 809 | 401 | 2.0167 | 1.3994 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.46 | 27.76 | 13 | 438 | 0.0296 | -0.1735 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.46 | 27.76 | 807 | 438 | 1.8398 | 1.3309 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.46 | 27.76 | 3 | 438 | 0.0068 | -0.4281 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 10.46 | 27.76 | 855 | 438 | 1.9492 | 1.3649 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.17 | 27.76 | 25 | 489 | 0.0511 | -0.0250 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.17 | 27.76 | 860 | 489 | 1.7584 | 1.2922 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.17 | 27.76 | 2 | 489 | 0.0041 | -0.4703 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 12.17 | 27.76 | 904 | 489 | 1.8484 | 1.3200 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 13.87 | 27.76 | 27 | 604 | 0.0446 | -0.0062 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 13.87 | 27.76 | 888 | 604 | 1.4685 | 1.1806 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 13.87 | 27.76 | 975 | 604 | 1.6123 | 1.2269 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 15.58 | 27.76 | 27 | 685 | 0.0394 | -0.0060 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 15.58 | 27.76 | 967 | 685 | 1.4105 | 1.1544 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 15.58 | 27.76 | 7 | 685 | 0.0102 | -0.2575 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 15.58 | 27.76 | 1027 | 685 | 1.4980 | 1.1826 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.28 | 27.76 | 34 | 838 | 0.0405 | 0.0421 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.28 | 27.76 | 1042 | 838 | 1.2424 | 1.0903 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 17.28 | 27.76 | 10 | 838 | 0.0119 | -0.1875 | MN20160318_Q01 | G18 |